Clinical trial / 2021
Autologous fecal microbiota transplantation collected during a green-Mediterranean diet phase significantly attenuated subsequent weight regain.
In the DIRECT PLUS trial, participants lost weight over 6 months on healthy guidelines, a Mediterranean diet, or a green-Mediterranean diet. Ninety participants provided fecal samples collected at month 6 and were randomized to receive capsules containing their own fecal microbiota (aFMT) or placebo until month 14. Across all participants, aFMT did not significantly reduce weight regain versus placebo (30.4% vs 40.6%, P = .28), but it significantly attenuated regain in the green-Mediterranean group (17.1% vs 50%, P = .02; P for interaction = .03). In this group, aFMT also reduced waist circumference gain (1.89 cm vs 5.05 cm, P = .01) and insulin rebound (P = .04).
- Study type
- Randomized controlled trial
- Who was studied
- 90 abdominally obese or dyslipidemic participants who lost weight
- What was measured
- Weight regain over months 6-14
THE PAPER
Effects of Diet-Modulated Autologous Fecal Microbiota Transplantation on Weight Regain.
Rinott E, Youngster I, Yaskolka Meir A, Tsaban G, Zelicha H, Kaplan A, Knights D, Tuohy K, Fava F, Scholz MU, Ziv O, Rubin E, Tirosh A, Rudich A, Blüher M, Stumvoll M, Ceglarek U, Clement K, Koren O, Wang DD, Hu FB, Stampfer MJ, Shai I. Gastroenterology, 2021.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.